Louis Moore Bacon's GDRX Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 938,564 shares of GoodRx Holdings, Inc. (GDRX) worth $2.54 M, representing 0.04% of the portfolio. First purchased in 2024-Q4, this short-term holding has been held for 4 quarters.
Based on 13F filings, Louis Moore Bacon has maintained this position in GDRX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 524,051 shares. Largest reduction occurred in Q1 2025, reducing 237,892 shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's GoodRx Holdings (GDRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly GoodRx Holdings (GDRX) Trades by Louis Moore Bacon
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +414,513 | Add 79.10% | 938,564 | $2.71 |
| Q3 2025 | +524,051 | New Buy | 524,051 | $4.23 |
| Q1 2025 | -237,892 | Sold Out | 0 | $0.00 |
| Q4 2024 | +237,892 | New Buy | 237,892 | $4.65 |
Louis Moore Bacon's GoodRx Holdings Investment FAQs
Louis Moore Bacon first purchased GoodRx Holdings, Inc. (GDRX) in Q4 2024, acquiring 237,892 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held GoodRx Holdings, Inc. (GDRX) for 4 quarters since Q4 2024.
Louis Moore Bacon's largest addition to GoodRx Holdings, Inc. (GDRX) was in Q3 2025, adding 524,051 shares worth $2.22 M.
According to the latest 13F filing for Q4 2025, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 938,564 shares of GoodRx Holdings, Inc. (GDRX), valued at approximately $2.54 M.
As of the Q4 2025 filing, GoodRx Holdings, Inc. (GDRX) represents approximately 0.04% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.
Louis Moore Bacon's peak holding in GoodRx Holdings, Inc. (GDRX) was 938,564 shares, as reported at the end of Q4 2025.